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Abstract
New fermented almond milks were developed, using different potentially probiotic bacteria, in order
to meet the current demand for healthy, versatile non-dairy products. An in vitro digestion/Caco-
2 cell model was used to evaluate the effect of both non-fermented and fermented almond milks on
the mitochondrial enzymatic activities of enterocytes. Moreover, macrophages were challenged with
the in-vitro digested samples and the production of pro-inflammatory biomarkers TNF-α and IL-6
was quantified. Enzymatic activities of cell cultures seemed to be stimulated by the exposure to both
fermented and non-fermented almond milks. Both biomarkers decreased (p< 0.05) in fermented almond
milks with either B. bifidum or B. longum. Results showed that fermented almond products favored the
energetic metabolism of enterocytes and had a lower inflammatory response than non-fermented almond
milk, suggesting its benefits for the management of allergies/intolerances. Moreover, the fermentation
process enhanced the uptake of iron by Caco-2 cells, especially when using L. rhamnosus and either
B. bifidum or B. longum as starters, thus improving the product bioactivity. Therefore, new non-
dairy fermented products with functional properties were developed, which might be positioned as
alternatives to cow-milk products for sensitized groups of population (allergic and/or intolerant to cow
milk or anemic population, among others).
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1 Introduction
The current alarming increase in the incidence
of allergic diseases in both children and adults
in developed countries has been attributed to
the so-called “hygiene hypothesis”; this theory
suggests that the increased level of hygiene in
both the environment and the food supply leads
to a reduced exposure to a variety of microbes,
which, early in life, is a crucial factor in the
development of allergies (Bjo¨rkste´n, 2009). In-
deed, several prospective follow-up studies have
found that alterations in gut microbiota precede
allergy development (Kallioma¨ki, 2010). Hence,
recent clinical allergy researches have principally
focused their attention on the manipulation of
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gut microbiota composition (Kallioma¨ki et al.,
2010). Nowadays, probiotics, prebiotics and
synbiotics (combination of pre- and probiotics)
are considered as good tools with which to
elicit changes in the gut biomass composition,
since they can improve and stimulate beneficial
gut microflora, among other effects that are
beneficial for the health. Since the late 1990s,
over 30 randomized clinical trials have been
published, in which probiotics have been used
either in the treatment or prevention of allergies
(mainly atopic diseases) (Kallioma¨ki et al.,
2010). Hence, considering the high prevalence of
atopic disease in childhood in the industrialized
countries (Anandan, Nurmatov, van Schayck, &
Sheikh, 2010), the use of yoghurt-type foods as
carriers of probiotics and/or synbiotics would
be helpful as a means of attaining the either
preventive or prophylactic treatment in this
targeted population. Moreover, despite the
little known and untrustworthy concept of
functional food, consumers are familiar with
yoghurt-type products and consider them as
healthy (Annunziata & Vecchio, 2011), which
would facilitate the inclusion of such functional
fermented products in their diets.
The immunomodulatory effects of fermented
dairy-milks, casein hydrolysates and soy-
beverage caused by lactic acid bacteria have
been widely reported (Baroja, Kirjavainen,
Hekmat, & Reid, 2007; Sutas et al., 1996;
Wagar, Champagne, Buckley, Raymond, &
Green-Johnson, 2009). However, in addition
to the allergenic proteins, both matrices might
provoke iron deficiencies in infants and toddlers.
On the one hand, the calcium together with
the casein provided by cow-milk are seen to
inhibit the absorption of dietary non-heme iron,
in addition to the intestinal blood loss observed
in approximately 40% of infants during feeding
with cow-milk and/or its derivatives (Agostoni
& Turck, 2011). On the other hand, soya-based
products contain phytates, which negatively
interfere in the absorption of iron, among other
minerals (Artazcoz, 2007).
By contrast, almond milk has not been reported
to interfere negatively in iron absorption. In-
deed, almonds have high anti-oxidant activity
owing to the α-tocopherol and polyphenolic
constituents (Chen, Lapsley, & Blumberg,
2006), which might improve the bioavailability
of dietary iron. As it has been reviewed,
although non-heme iron is easily oxidized (not
bioavailable) due to the rise of pH in the
lumen, the presence of reductants from food can
maintain this micronutrient in its reduced form
and, therefore, positively improve its absorption
(Miret, Simpson, & McKie, 2003). Moreover,
almond milk is considered an appropriate alter-
native to cow-milk, since, besides the healthy
lipid profile, it has a low ratio of Na/K and a
balanced ratio of Ca/P (Luengo, 2009).
Nevertheless, with regards to the inflammatory
response, there is lack of data concerning nut
beverages, and least when it comes to derivative
fermented products. Only recently has data
appeared on almonds (Rajaram, Connell, &
Sabate, 2010), in which the authors studied
whether, in addition to the lowering of blood
lipids, monounsaturated fat-rich almonds influ-
enced other coronary heart disease risk factors,
such as inflammation. The study concluded
that incorporating about 68 g almonds in a 2000
kcal cholesterol-lowering diet decreased serum
E-selectin (molecules which are indicative of
endothelial dysfunction) and C-reactive protein
(sensitive marker of inflammation that, in high
concentrations, is strongly linked with coronary
events, stroke and peripheral vascular disease)
in healthy men and women.
Although around 50% of almond composition is
fat, intakes of 7g per day of this nut have been
shown to reduce low-density lipoprotein choles-
terol concentration by 1% (Sabate´, Haddad,
Tanzman, Jambazian, & Rajaram, 2003) and up
to 84 g per day can be consumed without weight
gain (Chen et al., 2006). In addition, these nuts
have a low glycemic index (they do not adversely
impact insulin sensitivity) (Chen et al., 2006)
and have been found to possess prebiotic effects,
since they stimulated the growth of gut bifi-
dobacteria and Eubacterium rectale (Mandalari,
Nueno-Palop, Bisignano, Wickham, & Narbad,
2008). Hence, taking into account the health
benefits of almond intake, almond milk might be
considered as a good food matrix with which to
obtain healthy fermented products. Moreover,
if the fermentation process is carried out by
potentially probiotic bacteria, the developed
fermented product could be useful as a means
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of preventing some immunomodulatory diseases,
such as allergies.
The Caco-2 cell line, commonly used in con-
junction with in vitro digestion techniques, is
a useful model for studying intestinal human
iron uptake, which it allows to occur simulta-
neously with food digestion, and is generally
regarded as the best available intestinal cell
model for studying the mechanisms associated
with vectorial iron transport (Glahn, Lee,
Yeung, Goldman, & Miller, 1998). In addition,
the macrophage-derived RAW 264.7 cell line
expresses key genes and proteins of principal
pathways for the production of regulatory
cytokines (Novak, Babcock, Jho, Helton, &
Espat, 2003) and constitutes a cell model used
worldwide and a useful tool with which to study
the inflammatory response(s) and metabolic
activity promoted by food-derived components
while still maintaining a rapid and inexpensive
system (Deepika, Rastall, & Charalampopoulos,
2011; Kabeerdoss et al., 2011).
The aim of this study, therefore, was to evaluate
whether almond milk, fermented with different
potential probiotic bacteria, affects both the
energetic metabolism in intestinal cells and the
production of pro-inflammatory biomarkers in
order to gain insights into the potential benefits
of the designed products for the consumer’s gut
health.
2 Materials and Methods
2.1 Preparation and fermentation
of almond milk
Almond milk was produced by soaking and
grinding almonds (Prunus amygdalus L. cv. dul-
cis) supplied by Frutos Secos 3G S.L. (Valen-
cia, Spain). The extraction was carried out in
the Sojamatic® 1.5 (Barcelona, Spain), equip-
ment specifically designed for the production
of vegetable milks, using a nut:water ratio of
8:100. The milky liquid obtained was then mi-
crofluidized in a high pressure homogenizer (M-
110P model; Microfluidics International Corpo-
ration, Westwood, MA, USA) by applying 172
MPa, sterilized (121 ◦C/15 min) and subse-
quently cooled down to 37 ◦C (fermentation tem-
perature).
Lactobacillus rhamnosus CECT 278, Lactobacil-
lus plantarum 3O9, Bifidobacterium bifidum
CECT 870, Bifidobacterium longum CECT 4551,
Streptococcus thermophilus CECT 986, Lacto-
bacillus delbrueckii subs. Bulgaricus CECT 4005
were used as starters, pure or mixed, as shown
in Table 2. All the bacteria were purchased from
CECT (Paterna, Spain), with the exception of
the L. plantarum 3O9 strain, which was isolated
from Guirra sheep milk and selected as a probi-
otic in previous studies (Amorocho Cruz, 2011).
For the preparation of starters inoculum, the
strains were independently incubated for 24 h
in their selective broths and then centrifuged at
100 g (Medigriger-BL-S, JP-Selecta; Barcelona,
Spain) for 10 min at 4 ◦C to re-suspend the pel-
let in PBS-1x buffer (10 mmol/L phosphate, 137
mmol/L NaCl, 2.7 mmol/L KCl, pH 7.4) until
reaching strain concentrations of 108 cfu/mL.
For each formulation, 1% (v/v) of starter sus-
pension was added to the almond milk and sub-
sequently incubated at 37 ◦C until pH values of
4.4-4.6 were reached, which was controlled by us-
ing a GLP 21+ pH-meter (Crison Instruments
S.A.; Barcelona, Spain). The fermented samples
were frozen and stored at -22 ◦C prior to anal-
ysis. A non-fermented almond sample was used
as a control (C).
2.2 Simulated gastrointestinal
digestion
The human gastrointestinal digestion process
was simulated by using porcine pepsin (800-
2, 500 units/mg protein), pancreatin (activity,
4 USP specifications) and bile, as previously de-
scribed by Laparra, Barbera, Alegria, Glahn, and
Miller (2009). All reagents were purchased from
Sigma-Aldrich Co. (St Louis, MO, USA). Prior
to the in vitro digestion, 1.5 mL aliquot of each
assayed sample was diluted in 5mL of a saline
solution (140 mmol/L NaCl, 5 mmol/L KCl ad-
justed to pH 3). For gastric digestion (pepsin in
0.1 mol/L HCl adjusted to pH 3; 1 h), samples
were placed on a rocking platform shaker in an
incubator (37 ◦C; 5% CO2; 95% relative humid-
ity). The intestinal digestion (pancreatin-bile ex-
tract in 0.1 mol/L NaHCO3 adjusted to pH 6.9-7;
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2 h) was carried out in the upper chamber of a
two-chamber system in 6-well plates.
The upper chamber was formed by fitting the
bottom of an appropriately sized Transwell in-
sert ring (Corning B.V. Life Sciences, Amster-
dam, The Netherlands) with a 15,000 molecu-
lar mass cut-off dialysis membrane (Spectra/Por
2.1, Spectrum Medical, Gardena, CA, USA).
Aliquots (1.5 mL) of the gastrointestinal digest
were loaded into the upper chambers and incu-
bated for 2 h. Afterwards, the inserts were re-
moved and the dialysates were diluted (1:4, v/v)
with culture media and incubated with intestinal
epithelial (Caco-2) or macrophage (RAW 264.7)
cells.
2.3 Ferritin analysis in intestinal
epithelial cell monolayer
Caco-2 cells were obtained from the American
Type Culture Collection (Rockville, MD, USA)
at passage 17 and used in experiments at pas-
sages 33 to 38. Cells were maintained with
Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco®, Madrid, Spain) under conditions pre-
viously described by Glahn et al. (1998).
For the assays, Caco-2 cells were seeded at 50,000
cell/cm2 in collagen-treated 6-well culture plates
(Costar, Cambridge, MA, USA), and were grown
with DMEM for 12 days. On the day prior to
the experiments, the DMEM medium was re-
placed by 2 mL of minimum essential medium
(MEM) (Gibco®, Madrid, Spain) and then the
cells were returned to the incubator. 50 µmol/L
of FeCl3 were added to the digested almond milk
samples and the ferritin formation by Caco-2
cells over a 24 h period was proportional to the
cell iron uptake. A latex-enhanced turbidimet-
ric immunoassay (Ferritin-turbilatex; Spinreact,
Girona, Spain) was used to measure the Caco-2
cell ferritin content, as Glahn et al. (1998) de-
scribed. The concentrations of ferritin were nor-
malized by the determination of the total protein
content in cell cultures by using a microLowry
kit (TP0200) (Sigma-Aldrich, St. Louis, MO,
USA). The control cells (basal), exposed to in
vitro digestions of control solutions containing
digestive enzymes but not sample, were moni-
tored throughout. Base-line cell ferritin in cul-
tures grown in MEM averaged 4.2 ng/mg cell
protein. The samples were analyzed in triplicate.
2.4 Mitochondria enzyme
activities
These activities were evaluated in Caco-2
cell cultures by monitoring MTT (3-(4,5-
dimethylthiazol-2-yl)-2,3-diphenyl tetrazolium
bromide) conversion on exposed cultures after
an incubation period of 3 h, following the
method described by Laparra et al. (2009). This
colorimetric method is based on the reduction
of the tetrazolium ring of MTT by mitochon-
dria dehydrogenases yielding a blue formazan
product, which can be measured spectropho-
tometrically. For the assays, Caco-2 cells were
seeded at 50,000 cell/cm2 in 24-well culture
plates (Costar, Cambridge, MA, USA), and were
grown with DMEM for 12 days. Control cells
(basal) exposed to digests containing enzymes
but not samples were used throughout each
assay. Four replicates were analyzed.
2.5 Analysis of pro-inflammatory
markers
The inflammatory analyses were carried out
following the method described by Novak et
al. (2003). For the assays, RAW 264.7 cells
were seeded at 50,000 cell/cm2 and were grown
with Roswell Park Memorial Institute (RPMI)
medium (Gibco®, Madrid, Spain) for 24 hours.
Tumor Necrosis Factor-α (TNF-α) and inter-
leukin 6 (IL-6) (eBioscience Ltd., Hatfield, UK)
were determined by ELISA, following the man-
ufacturer’s instructions, on exposed RAW 264.7
cell cultures after an incubation period of 3 h.
Results were expressed as picograms per mL of
media. Four replicates were analyzed.
2.6 Statistical analysis
Each of the experiments was conducted on four
independent replicates. A one-way analysis of
variance (ANOVA) and the Tukey post hoc test
were applied. Statistical significance was estab-
lished at a confidence level of 95% for all the
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comparisons. SPSS v.15 software (SPSS Inc.,
Chicago, IL, USA) was used for the statistical
analysis.
3 Results and Discussion
3.1 Almond milk and their
fermented-derivative products
The use of high pressure homogenization (HPH)
contributed to a better stability of the almond
milk, since this emergent microfluidization tech-
nology is able to reduce the size of fat glob-
ule particles, greatly delaying the flocculation
and coagulation phenomena (Lujan Capra et al.,
2009; Cruz et al., 2009).
The chemical composition of the almond milk
used for fermentations, which is subsequently
codified as control (C), is summarized in Table
1. Taking into account the nut:water ratio used,
these values are similar to those found in the lit-
erature (Yada, Lapsley, & Huang, 2011).
The initial pH of the almond milk (C) was 6.61
± 0.08. A significant decline in pH to 4.60 ± 0.02
after 20 h at 37 ◦C of incubation, took place in
the developed products along with a correspond-
ing increase in acidity caused by fermentation.
Table 1: Chemical composition of almond milks
used in the study. Values (mean ± standard de-
viation) are expressed as grams per 100 mL of
beverage.
Compound Concentration
Dry matter 6.64 ± 0.5
Lipids 3.96 ± 0.2
Proteins 1.37 ± 0.03
Total sugars 0.41 ± 0.002
Ashes 0.325 ± 0.012
Fiber 0.58*
* Fiber concentration was obtained by subtracting the
dry matter content from the sum of the rest of com-
pounds shown.
3.2 Bacterial fermentation effects
on TNFα and IL-6 production
Figure 1 shows the Tumor necrosis factor
(TNF)-α and interleukin (IL)-6 production in
macrophage (RAW 264.7 cells) cultures exposed
to digests of fermented milks. A non-fermented
almond milk was used as a control (C).
Focusing on the cells treated with dialyzable frac-
tion samples not fermented by using bifidobacte-
ria (F1 to F5) (Table 2), fermentation with ei-
ther L. rhamnosus (F2) or L. plantarum (F3)
decreased the TNF-α production (p< 0.05) by a
similar amount with respect to the control (C).
When the standard yoghurt bacteria was used
(F1), the TNF-α production was similar to the
control. Opposite effects were observed when the
fermentation was developed by combining those
lactobacilli with standard yoghurt bacteria (F4
and F5, respectively), since the TNF-α produc-
tion increased (p< 0.05) compared to the con-
trol (Figure 1). As regards the IL-6, and con-
trary to that observed in TNF-α, all samples had
a positive effect in the production of this pro-
inflammatory marker with respect to the control,
especially when the almond milk fermentation
was done by using mixed-cultures (F4 and F5).
These samples exhibited the lowest IL-6 concen-
trations (p< 0.05), showing 55-70% of inhibition
(p< 0.05) of the initial IL-6 production induced
by non-fermented almond milk (C) (Figure 1).
With respect to the samples fermented using the
bifidobacteria (F6 to F11), all the cells exposed
to those dialyzed samples exhibited a very low
TNF-α production in comparison to the con-
trol (p< 0.05). When considering IL-6 produc-
tion, different patterns were observed depending
on the type of bifidobacteria present in starter.
As Figure 1 shows, the fractions from fermented
samples with B. bifidum (F6, F8 and F10) in-
duced cells to produce IL-6 amounts similar to
that obtained in fermented samples with stan-
dard yoghurt bacteria (F1). However, with B.
longum (F7, F9 and F11) lower (p< 0.05) IL-6
concentrations were quantified, especially when
it was combined with either standard yoghurt
bacteria (F7) or L. plantarum (F11).
TNF-α is a pro-inflammatory factor produced
by macrophages that exerts important effects on
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Figure 1: Tumor necrosis factor (TNF)-α and interleukin (IL)-6 production in macrophage (RAW 264.7
cells) cultures exposed to digests of fermented milks. C: non-fermented almond milk. Basal: cells not
exposed to samples.* a-e Different superscript letters indicate significant differences between samples in TNF-α
production (p< 0.05). * w-z Different superscript letters indicate significant differences between samples in IL-6
production (p< 0.05).
Table 2: Microbial strains used to produce the different fermented almond milks.
Formulation Starters inoculum
C - - -
F1 - - S. thermophilus + L. delbrueckii
F2 L. rhamnosus - -
F3 L. plantarum - -
F4 L. rhamnosus - S. thermophilus + L. delbrueckii
F5 L. plantarum - S. thermophilus + L. delbrueckii
F6 - B. bifidum S. thermophilus + L. delbrueckii
F7 - B. longum S. thermophilus + L. delbrueckii
F8 L. rhamnosus B. bifidum -
F9 L. rhamnosus B. longum -
F10 L. plantarum B. bifidum -
F11 L. plantarum B. longum -
L.: Lactobacillus B.: Bifidobacterium S.: Streptococcus
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systemic inflammation and induces the produc-
tion of other inflammatory cytokines such as IL-
6 or IL-8 (Hu, Kobayashi, Zenda, & Shimamura,
1997). The observed bacterial fermentation ef-
fects could have important consequences on the
intestinal barrier function because TNF-α plays
a crucial role by increasing paracellular perme-
ability and impairing tight junction functionality
(Ma et al., 2004) and leukocyte infiltration in the
intestinal wall (Hoffman, 2000). In addition, the
reduction in TNF-α production might also have
important physiological consequences preventing
allergic inflammatory processes.
Almonds are known to have several nutritional
benefits, including that of lowering cholesterol
and protection against diabetes (Rajaram et al.,
2010; Sabate´ et al., 2003). Furthermore, sci-
entific studies have pointed to their potential
prebiotic and anti-inflammatory activities (Ra-
jaram et al., 2010; Mandalari et al., 2008). Al-
mond lipids and carbohydrates available for fer-
mentation have been associated with increasing
both the number of bifidobacteria strains and
the short chain fatty acids (SCFA) content, es-
pecially in butyrate concentrations (Mandalari
et al., 2008). Butyric acid has the potential
to benefit colonic health, since it reduces hy-
drogen peroxide in cells and maintains their in-
tegrity (Scott, Martin, Duncan, & Flint, 2014).
Although bifidobacteria strains are not able to
produce butyrate, they synthesize other SCFA
such as acetate which can be used by other bac-
teria (i.e. lactobacilli) in their metabolic route
to synthesize this cells’ protective acid (Falony,
Vlachou, Verbrugghe, & De Vuyst, 2006). More-
over, this butyric production may be enhanced
in the presence of prebiotics (i.e. almond fibers)
(Falony et al., 2006; Scott et al., 2014). These
facts are coherent and might explain the marked
positive effects observed in the inflammatory re-
sponses induced by dialysates from samples in-
oculated with bifidobacteria. Nevertheless, the
active components above mentioned (SCFA and
prebiotics) have not been analysed since they
were beyond the objective of this study.
As the results suggest, the involvement of ei-
ther B. bifidum or B. longum in the develop-
ment of fermented almond-based products might
be of interest in order to reduce inflammatory
intestinal processes of a targeted population. In-
deed, previous in vitro and in vivo studies carried
out by using these bacteria species also showed
positive effects in immunomodulatory responses
(Laparra, Olivares, Gallina, & Sanz, 2012; La-
parra & Sanz, 2010). Nevertheless, despite the
results, the differences from different probiotic
strains used are yet to be investigated in detail.
3.3 Bacterial fermentation effects
on energetic metabolism of
intestinal cells
Results of the possible toxicity of fermented sam-
ples in intestinal epithelial (Caco-2) cells, which
was quantified by monitoring the mitochondrial
enzyme (MTT test) activities, are shown in Fig-
ure 2. The intestinal epithelium constitutes
the first physiological barrier to exogenous com-
pounds and nutrient absorption. Mitochon-
dria and endo-lysosomal enzyme activities were
proven to be sensitive biomarkers of changes in
cellular metabolism in response to internalized
food-derived compounds (Laparra et al., 2009;
Wu et al., 2010). This MTT assay showed
that none of the dialysates exposed to cell cul-
tures seem to cause toxic effects, as concluded
from the fact that the MTT values were similar
(p< 0.05) to those calculated for basal culture
(cells not exposed to almond milk samples). As
mentioned above, possible synergism between al-
mond constituents (prebiotics) and starter bacte-
ria might have produced cell protective bioactive
compounds (i.e. butyrate) (Falony et al., 2006;
Scott et al., 2014) which prevented alterations
of the Caco-2 mythocondria and endo-lyososomal
enzymatic activity.
Particularly, the MTT values showed that
dialysates from samples fermented with L. plan-
tarum 3O9 (F3) (Table 2) stimulated the en-
ergetic cell metabolism, similar to that of non-
fermented almond milk (C) (p< 0.05). How-
ever, when these bacteria were used in combina-
tion with standard yoghurt bacteria, the resulted
dialysates (F4 and F5) did not have this signifi-
cant stimulatory effect.
Both MTT results (Figure 2) and the ones ob-
tained in the production of pro-inflammatory cy-
tokines by immune cells (Figure 1) indicated that
almond fermented products might exert benefi-
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Figure 2: MTT conversion percentages in Caco-2 cell cultures exposed to digests of fermented milks.
(C: non-fermented almond milk; Basal: cells not exposed to samples). * a,b Different superscript letters
indicate significant differences(p< 0.05) between samples.
cial effects on human gut health, especially when
using standard yoghurt bacteria with B. longum
(F7) and L. rhamnosus with B. longum (F9) as
starters.
3.4 Iron uptake in the presence of
fermented almond milk
Ferritin concentrations in cell cultures exposed
to different dialyzed fermented almond milks are
shown in Figure 3. Apparently, the fermenta-
tion process improved the bioavailability of iron,
since the resultant Caco-2 iron uptake in every
fermented formulation was higher than that ob-
tained in the cells exposed to non-fermented al-
mond milk dialysates (C) (p< 0.05). In par-
ticular, samples fermented with L. rhamnosus,
with either B. bifidum (F8) or B. longum (F9),
were the ones which induced the most iron up-
take (p< 0.05). Previous studies have also shown
the in vitro enhancing effect of probiotic bacte-
ria on iron uptake in fermented vegetable ma-
trices, such as carrot juice (Bergqvist, Andlid,
& Sandberg, 2006), maize (Proulx & Reddy,
2007) or beans (Laparra, Tako, Glahn, & Miller,
2008). This study, hence, extends the bacterial-
mediated positive effects on iron uptake from fer-
mented vegetable products, particularly those in
which the starter culture contains bifidobacte-
ria strains. In addition, it has been reported
that almond extracts exhibited excellent metal
ion chelation efficacies (ability to maintain oli-
goelements such as iron in the reduced form
needed to be absorbed by the epithelial cells),
owing to its source of bioactive polyphenols with
antioxidant activity (Garrido, Monagas, Gomez-
Cordoves, & Bartolome, 2008; Wijeratne, Abou-
Zaid, & Shahidi, 2006). These almond-derived
components with functional characteristics may
also be present in the fermented samples and
might explain, at least in part, the effects ob-
served.
Therefore, as Figure 3 suggested, fermented
almond milk may provide health benefits to
IJFS April 2015 Volume 4 pages 49–60
Fermented almond milks improve bioavailability of iron 57
Figure 3: Ferritin concentration in Caco-2 cultures exposed to digested fermented milks with added
FeCl3 (50 µmol/L). (MEM: Minimum Essential Medium; C: non-fermented almond milk; Basal: cells
not exposed to samples).* a,e Different superscript letters indicate significant differences (p< 0.05) between
samples.
consumers owing to its ability to increase the
bioavailability of dietary iron. Moreover, this
positive effect observed could have important
consequences as fermented almond milk might
preserve the nutritional iron status in the pedi-
atric community which appears to be the most
susceptible population to the negative effects of
cow-milk. Furthermore, the intake of this type
of product could reduce allergies and intolerances
derived from the consumption of cow-milk by this
population (Agostoni & Turck, 2011).
4 Conclusions
This study has shown that almond milk fer-
mented with potentially probiotic bacteria ex-
erted positive immunomodulatory effects on
macrophages and did not impair negative effects
on the energetic metabolism of intestinal epithe-
lial cells, especially when this vegetable milk was
fermented with either standard yoghurt bacte-
ria and B. longum CECT 4551 or L. rhamnosus
CECT 278 and B. longum. Moreover, some com-
binations of specific strains had markedly signifi-
cant positive effects on the iron uptake by intesti-
nal epithelial cells that could help to improve the
nutritional status of targeted consumers. In par-
ticular, samples inoculated with L. rhamnosus
CECT 278 and either B. bifidum CECT 870 or
B. longum CECT 4551 exhibited the highest fer-
ritin concentrations in Caco-2 cultures. The ob-
tained results also suggest an improvement in the
bioactivity of almond milk due to fermentation;
nevertheless, the identification of biologically ac-
tive components is needed and will provide fur-
ther insights into the potential nutritional and
health benefits of fermented almond-based prod-
ucts. To sum up, the results suggest that almond
milk fermented with potentially probiotic bacte-
IJFS April 2015 Volume 4 pages 49–60
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ria may be beneficial for human gut health and,
hence, might be helpful in managing cow-milk
allergies and/or intolerances.
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